Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors.

Mesa, Ruben A

Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors. [electronic resource] - Leukemia & lymphoma Jul 2015 - 1989-99 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1029-2403

10.3109/10428194.2014.983098 doi


Disease Management
Humans
Janus Kinases--antagonists & inhibitors
Myeloproliferative Disorders--drug therapy
Prognosis
Protein Kinase Inhibitors--therapeutic use